SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

agilon health, inc. – ‘10-Q’ for 9/30/22 – ‘EX-101.SCH’

On:  Thursday, 11/3/22, at 4:24pm ET   ·   For:  9/30/22   ·   Accession #:  950170-22-21905   ·   File #:  1-40332

Previous ‘10-Q’:  ‘10-Q’ on 8/4/22 for 6/30/22   ·   Next:  ‘10-Q’ on 5/9/23 for 3/31/23   ·   Latest:  ‘10-Q’ on 11/2/23 for 9/30/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/03/22  agilon health, inc.               10-Q        9/30/22   74:10M                                    Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   3.50M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
11: R1          Document and Entity Information                     HTML     76K 
12: R2          Condensed Consolidated Balance Sheets               HTML    135K 
13: R3          Condensed Consolidated Balance Sheets               HTML     48K 
                (Parenthetical)                                                  
14: R4          Condensed Consolidated Statements of Operations     HTML    145K 
15: R5          Consolidated Statements of Operations               HTML     24K 
                (Parenthetical)                                                  
16: R6          Condensed Consolidated Statements of Comprehensive  HTML     50K 
                Income (Loss)                                                    
17: R7          Condensed Consolidated Statements of Contingently   HTML    124K 
                Redeemable Common Stock and Stockholders' Equity                 
                (Deficit)                                                        
18: R8          Condensed Consolidated Statements of Cash Flows     HTML     97K 
19: R9          Business                                            HTML     29K 
20: R10         Summary of Significant Accounting Policies          HTML     45K 
21: R11         Revenue, Receivables, and Concentration of Credit   HTML     94K 
                Risk                                                             
22: R12         Marketable Securities and Fair Value Measurements   HTML    113K 
23: R13         Other Assets, net                                   HTML     60K 
24: R14         Medical Claims and Related Payables                 HTML     90K 
25: R15         Other Liabilities                                   HTML     55K 
26: R16         Debt                                                HTML     51K 
27: R17         Commitments and Contingencies                       HTML     38K 
28: R18         Common Stock                                        HTML     36K 
29: R19         Net Income (Loss) Per Common Share                  HTML    135K 
30: R20         Discontinued Operations                             HTML    161K 
31: R21         Supplemental Cash Flow Information                  HTML     82K 
32: R22         Variable Interest Entities                          HTML    149K 
33: R23         Summary of Significant Accounting Policies          HTML    134K 
                (Policies)                                                       
34: R24         Revenue, Receivables, and Concentration of Credit   HTML     86K 
                Risk (Tables)                                                    
35: R25         Marketable Securities and Fair Value Measurements   HTML    106K 
                (Tables)                                                         
36: R26         Other Assets, net (Tables)                          HTML     56K 
37: R27         Medical Claims and Related Payables (Tables)        HTML     86K 
38: R28         Other Liabilities (Tables)                          HTML     51K 
39: R29         Net Income (Loss) Per Common Share (Tables)         HTML    135K 
40: R30         Discontinued Operations (Tables)                    HTML    161K 
41: R31         Supplemental Cash Flow Information (Tables)         HTML     84K 
42: R32         Variable Interest Entities (Tables)                 HTML    147K 
43: R33         Business - Additional Information (Details)         HTML     27K 
44: R34         Summary of Significant Accounting Policies -        HTML     42K 
                Additional Information (Details)                                 
45: R35         Revenue, Receivables, and Concentration of Credit   HTML     29K 
                Risk - Additional Information (Details)                          
46: R36         Revenue, Receivables, and Concentration of Credit   HTML     43K 
                Risk - Schedules of Concentration of Risk as a                   
                Percentage of Revenues and Receivables (Details)                 
47: R37         Revenue, Receivables, and Concentration of Credit   HTML     29K 
                Risk - Schedules of Concentration of Risk as a                   
                Percentage of Revenues and Receivables                           
                (Parenthetical) (Details)                                        
48: R38         Marketable Securities and Fair Value Measurements   HTML     41K 
                - Schedule of marketable debt securities (Details)               
49: R39         Marketable Securities and Fair Value Measurements   HTML     44K 
                - Schedule of fair value on a recurring basis                    
                (Details)                                                        
50: R40         Marketable Securities and Fair Value Measurements   HTML     30K 
                - Additional Information (Details)                               
51: R41         Other Assets, net - Schedule of Other Assets, Net   HTML     40K 
                (Details)                                                        
52: R42         Medical Claims and Related Payables - Summary       HTML     49K 
                Changes in Medical Claims and Related Payables                   
                (Details)                                                        
53: R43         Other Liabilities - Summary of Other Liabilities    HTML     35K 
                (Details)                                                        
54: R44         Other Liabilities - Additional Information          HTML     33K 
                (Details)                                                        
55: R45         Debt - Additional Information (Details)             HTML    103K 
56: R46         Commitments and Contingencies - Additional          HTML     27K 
                Information (Details)                                            
57: R47         Common Stock - Additional Information (Details)     HTML     42K 
58: R48         Net Income (Loss) Per Common Share - Computation    HTML     79K 
                of Basic and Diluted EPS (Details)                               
59: R49         Net Income (Loss) Per Common Share - Summary of     HTML     32K 
                Weighted-average Potential Shares of Common Stock                
                Were Excluded From Calculation of Diluted Net                    
                Income (Loss) Per Share Attributable to Common                   
                Stockholders (Details)                                           
60: R50         Discontinued Operations - Additional Information    HTML     26K 
                (Details)                                                        
61: R51         Discontinued Operations - Summary of Results of     HTML     62K 
                Discontinued Operations (Details)                                
62: R52         Discontinued Operations - Summary of Significant    HTML     24K 
                Non-Cash Operating Items for Discontinued                        
                Operations (Details)                                             
63: R53         Supplemental Cash Flow Information - Summary of     HTML     38K 
                Supplemental Cash Flow Information (Details)                     
64: R54         Supplemental Cash Flow Information - Summary of     HTML     32K 
                Cash, Cash Equivalents and Restricted Cash                       
                Equivalents from Continuing Operations (Details)                 
65: R55         Variable Interest Entities - Summary of             HTML     56K 
                Consolidated Asset and Liabilities Include VIE                   
                Assets and Liabilities (Details)                                 
66: R56         Variable Interest Entities - Additional             HTML     39K 
                Information (Details)                                            
67: R57         Variable Interest Entities - Schedule of Equity     HTML     33K 
                Method Investments (Details)                                     
68: R58         Variable Interest Entities - Summary of Operating   HTML     54K 
                Results (Details)                                                
69: R59         Variable Interest Entities - Summary of Operating   HTML     24K 
                Results (Parenthetical) (Details)                                
72: XML         IDEA XML File -- Filing Summary                      XML    136K 
70: XML         XBRL Instance -- agl-20220930_htm                    XML   2.44M 
71: EXCEL       IDEA Workbook of Financial Reports                  XLSX    125K 
10: EX-101.CAL  XBRL Calculations -- agl-20220930_cal                XML    137K 
 8: EX-101.DEF  XBRL Definitions -- agl-20220930_def                 XML    637K 
 7: EX-101.LAB  XBRL Labels -- agl-20220930_lab                      XML   1.18M 
 9: EX-101.PRE  XBRL Presentations -- agl-20220930_pre               XML    903K 
 6: EX-101.SCH  XBRL Schema -- agl-20220930                          XSD    159K 
73: JSON        XBRL Instance as JSON Data -- MetaLinks              398±   624K 
74: ZIP         XBRL Zipped Folder -- 0000950170-22-021905-xbrl      Zip    329K

‘EX-101.SCH’   —   XBRL Schema — agl-20220930

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-11-03T11:09:42.4584+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://agilonhealth.com/20220930" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2022" xmlns:agl="http://agilonhealth.com/20220930" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
<xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
<xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
<xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
<xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
<xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
<xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022"/>
<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="agl-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="agl-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="agl-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="agl-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
<link:definition> 100000 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETS" id="Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETS">
<link:definition> 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" id="Role_StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
<link:definition> 100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperations2" id="StatementCondensedConsolidatedStatementsOfOperations2">
<link:definition> 100030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 2 </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" id="Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
<link:definition> 100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/StatementConsolidatedStatementsOfOperationsParenthetical" id="StatementConsolidatedStatementsOfOperationsParenthetical">
<link:definition> 100050 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss" id="StatementCondensedConsolidatedStatementsOfComprehensiveIncomeLoss">
<link:definition> 100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCONTINGENTLYREDEEMABLECOMMONSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" id="Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCONTINGENTLYREDEEMABLECOMMONSTOCKANDSTOCKHOLDERSEQUITYDEFICIT">
<link:definition> 100070 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CONTINGENTLY REDEEMABLE COMMON STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" id="Role_StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
<link:definition> 100080 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureBusiness" id="Role_DisclosureBusiness">
<link:definition> 100090 - Disclosure - Business </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
<link:definition> 100100 - Disclosure - Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureRevenueReceivablesAndConcentrationOfCreditRisk" id="Role_DisclosureRevenueReceivablesAndConcentrationOfCreditRisk">
<link:definition> 100110 - Disclosure - Revenue, Receivables, and Concentration of Credit Risk </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurements" id="DisclosureMarketableSecuritiesAndFairValueMeasurements">
<link:definition> 100120 - Disclosure - Marketable Securities and Fair Value Measurements </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/DisclosureOtherAssetsNet" id="DisclosureOtherAssetsNet">
<link:definition> 100130 - Disclosure - Other Assets, net </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureMedicalClaimsAndRelatedPayables" id="Role_DisclosureMedicalClaimsAndRelatedPayables">
<link:definition> 100140 - Disclosure - Medical Claims and Related Payables </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureOtherLiabilities" id="Role_DisclosureOtherLiabilities">
<link:definition> 100150 - Disclosure - Other Liabilities </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureDebt" id="Role_DisclosureDebt">
<link:definition> 100160 - Disclosure - Debt </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
<link:definition> 100170 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureCommonStock" id="Role_DisclosureCommonStock">
<link:definition> 100180 - Disclosure - Common Stock </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureNetIncomeLossPerCommonShare" id="Role_DisclosureNetIncomeLossPerCommonShare">
<link:definition> 100190 - Disclosure - Net Income (Loss) Per Common Share </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureDiscontinuedOperations" id="Role_DisclosureDiscontinuedOperations">
<link:definition> 100200 - Disclosure - Discontinued Operations </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureSupplementalCashFlowInformation" id="Role_DisclosureSupplementalCashFlowInformation">
<link:definition> 100210 - Disclosure - Supplemental Cash Flow Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureVariableInterestEntities" id="Role_DisclosureVariableInterestEntities">
<link:definition> 100220 - Disclosure - Variable Interest Entities </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
<link:definition> 100230 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 100240 - Disclosure - Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureRevenueReceivablesAndConcentrationOfCreditRiskTables" id="Role_DisclosureRevenueReceivablesAndConcentrationOfCreditRiskTables">
<link:definition> 100250 - Disclosure - Revenue, Receivables, and Concentration of Credit Risk (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsTables" id="DisclosureMarketableSecuritiesAndFairValueMeasurementsTables">
<link:definition> 100260 - Disclosure - Marketable Securities and Fair Value Measurements (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/DisclosureOtherAssetsNetTables" id="DisclosureOtherAssetsNetTables">
<link:definition> 100270 - Disclosure - Other Assets, net (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureMedicalClaimsAndRelatedPayablesTables" id="Role_DisclosureMedicalClaimsAndRelatedPayablesTables">
<link:definition> 100280 - Disclosure - Medical Claims and Related Payables (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureOtherLiabilitiesTables" id="Role_DisclosureOtherLiabilitiesTables">
<link:definition> 100290 - Disclosure - Other Liabilities (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureNetIncomeLossPerCommonShareTables" id="Role_DisclosureNetIncomeLossPerCommonShareTables">
<link:definition> 100300 - Disclosure - Net Income (Loss) Per Common Share (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureDiscontinuedOperationsTables" id="Role_DisclosureDiscontinuedOperationsTables">
<link:definition> 100310 - Disclosure - Discontinued Operations (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureSupplementalCashFlowInformationTables" id="Role_DisclosureSupplementalCashFlowInformationTables">
<link:definition> 100320 - Disclosure - Supplemental Cash Flow Information (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureVariableInterestEntitiesTables" id="Role_DisclosureVariableInterestEntitiesTables">
<link:definition> 100330 - Disclosure - Variable Interest Entities (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureBusinessAdditionalInformationDetails" id="Role_DisclosureBusinessAdditionalInformationDetails">
<link:definition> 100340 - Disclosure - Business - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
<link:definition> 100350 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureRevenueReceivablesAndConcentrationOfCreditRiskAdditionalInformationDetails" id="Role_DisclosureRevenueReceivablesAndConcentrationOfCreditRiskAdditionalInformationDetails">
<link:definition> 100360 - Disclosure - Revenue, Receivables, and Concentration of Credit Risk - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureRevenueReceivablesAndConcentrationOfCreditRiskSchedulesOfConcentrationOfRiskAsPercentageOfRevenuesAndReceivablesDetails" id="Role_DisclosureRevenueReceivablesAndConcentrationOfCreditRiskSchedulesOfConcentrationOfRiskAsPercentageOfRevenuesAndReceivablesDetails">
<link:definition> 100370 - Disclosure - Revenue, Receivables, and Concentration of Credit Risk - Schedules of Concentration of Risk as a Percentage of Revenues and Receivables (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureRevenueReceivablesAndConcentrationOfCreditRiskSchedulesOfConcentrationOfRiskAsPercentageOfRevenuesAndReceivablesParentheticalDetails" id="Role_DisclosureRevenueReceivablesAndConcentrationOfCreditRiskSchedulesOfConcentrationOfRiskAsPercentageOfRevenuesAndReceivablesParentheticalDetails">
<link:definition> 100380 - Disclosure - Revenue, Receivables, and Concentration of Credit Risk - Schedules of Concentration of Risk as a Percentage of Revenues and Receivables (Parenthetical) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableDebtSecuritiesDetails" id="DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfMarketableDebtSecuritiesDetails">
<link:definition> 100390 - Disclosure - Marketable Securities and Fair Value Measurements - Schedule of marketable debt securities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueOnARecurringBasisDetails" id="DisclosureMarketableSecuritiesAndFairValueMeasurementsScheduleOfFairValueOnARecurringBasisDetails">
<link:definition> 100400 - Disclosure - Marketable Securities and Fair Value Measurements - Schedule of fair value on a recurring basis (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails" id="DisclosureMarketableSecuritiesAndFairValueMeasurementsAdditionalInformationDetails">
<link:definition> 100410 - Disclosure - Marketable Securities and Fair Value Measurements - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/DisclosureOtherAssetsNetScheduleOfOtherAssetsNetDetails" id="DisclosureOtherAssetsNetScheduleOfOtherAssetsNetDetails">
<link:definition> 100420 - Disclosure - Other Assets, net - Schedule of Other Assets, Net (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureMedicalClaimsAndRelatedPayablesSummaryChangesInMedicalClaimsAndRelatedPayablesDetails" id="Role_DisclosureMedicalClaimsAndRelatedPayablesSummaryChangesInMedicalClaimsAndRelatedPayablesDetails">
<link:definition> 100430 - Disclosure - Medical Claims and Related Payables - Summary Changes in Medical Claims and Related Payables (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureOtherLiabilitiesSummaryOfOtherLiabilitiesDetails" id="Role_DisclosureOtherLiabilitiesSummaryOfOtherLiabilitiesDetails">
<link:definition> 100440 - Disclosure - Other Liabilities - Summary of Other Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureOtherLiabilitiesAdditionalInformationDetails" id="Role_DisclosureOtherLiabilitiesAdditionalInformationDetails">
<link:definition> 100450 - Disclosure - Other Liabilities - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails" id="Role_DisclosureDebtAdditionalInformationDetails">
<link:definition> 100460 - Disclosure - Debt - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
<link:definition> 100470 - Disclosure - Commitments and Contingencies - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureCommonStockAdditionalInformationDetails" id="Role_DisclosureCommonStockAdditionalInformationDetails">
<link:definition> 100480 - Disclosure - Common Stock - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureNetIncomeLossPerCommonShareComputationOfBasicAndDilutedEPSDetails" id="Role_DisclosureNetIncomeLossPerCommonShareComputationOfBasicAndDilutedEPSDetails">
<link:definition> 100490 - Disclosure - Net Income (Loss) Per Common Share - Computation of Basic and Diluted EPS (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureNetIncomeLossPerCommonShareSummaryOfWeightedAveragePotentialSharesOfCommonStockWereExcludedFromCalculationOfDilutedNetIncomeLossPerShareAttributableToCommonStockholdersDetails" id="Role_DisclosureNetIncomeLossPerCommonShareSummaryOfWeightedAveragePotentialSharesOfCommonStockWereExcludedFromCalculationOfDilutedNetIncomeLossPerShareAttributableToCommonStockholdersDetails">
<link:definition> 100500 - Disclosure - Net Income (Loss) Per Common Share - Summary of Weighted-average Potential Shares of Common Stock Were Excluded From Calculation of Diluted Net Income (Loss) Per Share Attributable to Common Stockholders (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureDiscontinuedOperationsAdditionalInformationDetails" id="Role_DisclosureDiscontinuedOperationsAdditionalInformationDetails">
<link:definition> 100510 - Disclosure - Discontinued Operations - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureDiscontinuedOperationsSummaryOfResultsOfDiscontinuedOperationsDetails" id="Role_DisclosureDiscontinuedOperationsSummaryOfResultsOfDiscontinuedOperationsDetails">
<link:definition> 100520 - Disclosure - Discontinued Operations - Summary of Results of Discontinued Operations (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureDiscontinuedOperationsSummaryOfSignificantNonCashOperatingItemsForDiscontinuedOperationsDetails" id="Role_DisclosureDiscontinuedOperationsSummaryOfSignificantNonCashOperatingItemsForDiscontinuedOperationsDetails">
<link:definition> 100530 - Disclosure - Discontinued Operations - Summary of Significant Non-Cash Operating Items for Discontinued Operations (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureSupplementalCashFlowInformationSummaryOfSupplementalCashFlowInformationDetails" id="Role_DisclosureSupplementalCashFlowInformationSummaryOfSupplementalCashFlowInformationDetails">
<link:definition> 100540 - Disclosure - Supplemental Cash Flow Information - Summary of Supplemental Cash Flow Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureSupplementalCashFlowInformationSummaryOfCashCashEquivalentsAndRestrictedCashEquivalentsFromContinuingOperationsDetails" id="Role_DisclosureSupplementalCashFlowInformationSummaryOfCashCashEquivalentsAndRestrictedCashEquivalentsFromContinuingOperationsDetails">
<link:definition> 100550 - Disclosure - Supplemental Cash Flow Information - Summary of Cash, Cash Equivalents and Restricted Cash Equivalents from Continuing Operations (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureVariableInterestEntitiesSummaryOfConsolidatedAssetAndLiabilitiesIncludeVIEAssetsAndLiabilitiesDetails" id="Role_DisclosureVariableInterestEntitiesSummaryOfConsolidatedAssetAndLiabilitiesIncludeVIEAssetsAndLiabilitiesDetails">
<link:definition> 100560 - Disclosure - Variable Interest Entities - Summary of Consolidated Asset and Liabilities Include VIE Assets and Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/Role_DisclosureVariableInterestEntitiesAdditionalInformationDetails" id="Role_DisclosureVariableInterestEntitiesAdditionalInformationDetails">
<link:definition> 100570 - Disclosure - Variable Interest Entities - Additional Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/DisclosureVariableInterestEntitiesScheduleOfEquityMethodInvestmentsDetails" id="DisclosureVariableInterestEntitiesScheduleOfEquityMethodInvestmentsDetails">
<link:definition> 100580 - Disclosure - Variable Interest Entities - Schedule of Equity Method Investments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/DisclosureVariableInterestEntitiesSummaryOfOperatingResultsDetails" id="DisclosureVariableInterestEntitiesSummaryOfOperatingResultsDetails">
<link:definition> 100590 - Disclosure - Variable Interest Entities - Summary of Operating Results (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://agilonhealth.com/20220930/taxonomy/role/DisclosureVariableInterestEntitiesSummaryOfOperatingResultsParentheticalDetails" id="DisclosureVariableInterestEntitiesSummaryOfOperatingResultsParentheticalDetails">
<link:definition> 100600 - Disclosure - Variable Interest Entities - Summary of Operating Results (Parenthetical) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element id="agl_VariableInterestEntitiesAbstract" name="VariableInterestEntitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_ConversionOfContingentlyRedeemableCommonStockInConnectionWithIpo" name="ConversionOfContingentlyRedeemableCommonStockInConnectionWithIpo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_CostsOfRsuVestings" name="CostsOfRsuVestings" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_CostsOfRsuVestingsShares" name="CostsOfRsuVestingsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="agl_DisposalGroupIncludingDiscontinuedOperationOperatingExpenseRecovery" name="DisposalGroupIncludingDiscontinuedOperationOperatingExpenseRecovery" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<xsd:element id="agl_DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" name="DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<xsd:element id="agl_DisposalGroupIncludingDiscontinuedOperationPolicyholderBenefitsAndClaimsIncurredHealthCare" name="DisposalGroupIncludingDiscontinuedOperationPolicyholderBenefitsAndClaimsIncurredHealthCare" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_ExtendedTermOfLettersOfCredit" name="ExtendedTermOfLettersOfCredit" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="agl_GainLossOnLeaseTerminations" name="GainLossOnLeaseTerminations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_IssuanceOfCommonStockShareUnderPartnersEquityAgreement" name="IssuanceOfCommonStockShareUnderPartnersEquityAgreement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="agl_IssuanceOfCommonStockUnderPartnerPhysicianGroupEquityAgreementsUponIpo" name="IssuanceOfCommonStockUnderPartnerPhysicianGroupEquityAgreementsUponIpo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_IssuanceOfCommonStockValueUnderPartnersEquityAgreement" name="IssuanceOfCommonStockValueUnderPartnersEquityAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<xsd:element id="agl_LeaseTerminationPayment" name="LeaseTerminationPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<xsd:element id="agl_NetProceedsFromCreditFacilityUsedForWorkingCapitalAndOtherGeneralCorporatePurposes" name="NetProceedsFromCreditFacilityUsedForWorkingCapitalAndOtherGeneralCorporatePurposes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_NoncashOrPartNoncashInvestmentInUnconsolidatedSubsidiaries" name="NoncashOrPartNoncashInvestmentInUnconsolidatedSubsidiaries" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_NumberOfDirectContractingEntities" name="NumberOfDirectContractingEntities" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="agl_NumberOfEquityMethodInvestments" name="NumberOfEquityMethodInvestments" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="agl_NumberOfGeographicalLocation" name="NumberOfGeographicalLocation" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<xsd:element id="agl_NumberOfMedicareAdvantageMembersEnrolledWithPrivateHealthPlans" name="NumberOfMedicareAdvantageMembersEnrolledWithPrivateHealthPlans" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
<xsd:element id="agl_NumberOfPayors" name="NumberOfPayors" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="agl_NumberOfPayorsEnteredToAgreement" name="NumberOfPayorsEnteredToAgreement" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="agl_NumberOfPhysicianGroupPartners" name="NumberOfPhysicianGroupPartners" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="agl_NumberOfWhollyOwnedRiskBearingEntities" name="NumberOfWhollyOwnedRiskBearingEntities" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="agl_OfferingCostsAccruedAtEndOfPeriod" name="OfferingCostsAccruedAtEndOfPeriod" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxes" name="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<xsd:element id="agl_OtherMedicalExpenses" name="OtherMedicalExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_PayorsAgreeToPayAdministrativePenaltyToDmhc" name="PayorsAgreeToPayAdministrativePenaltyToDmhc" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_PenaltyAmountRelatedToDhmcAudit" name="PenaltyAmountRelatedToDhmcAudit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_PhysicianCompensationExpense" name="PhysicianCompensationExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="agl_PrepaymentProvisionOfLongTermLineOfCredit" name="PrepaymentProvisionOfLongTermLineOfCredit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<xsd:element id="agl_SharesWithheldRelatedToNetShareSettlement" name="SharesWithheldRelatedToNetShareSettlement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="agl_CommitmentsAndContingenciesLineItems" name="CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_DescriptionOfBusinessLineItems" name="DescriptionOfBusinessLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_OtherAssetsLineItems" name="OtherAssetsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_OtherLiabilitiesLineItems" name="OtherLiabilitiesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_CaliforniaOperationsMember" name="CaliforniaOperationsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_ContingentlyRedeemableCommonStockMember" name="ContingentlyRedeemableCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_DceInvestmentMember" name="DceInvestmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_DepreciationAndAmortization1Member" name="DepreciationAndAmortization1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_DirectContractingEntitiesMember" name="DirectContractingEntitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_EquityAwardsMarketAndOrPerformanceConditionMember" name="EquityAwardsMarketAndOrPerformanceConditionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_EquityMethodInvestmentsOtherMember" name="EquityMethodInvestmentsOtherMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_FormerChiefExecutiveOfficerMember" name="FormerChiefExecutiveOfficerMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_FresnoCaliforniaOperationsMember" name="FresnoCaliforniaOperationsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_GeneralAndAdministrative1Member" name="GeneralAndAdministrative1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_HawaiiReportingUnitMember" name="HawaiiReportingUnitMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_HealthPlanDepositsMember" name="HealthPlanDepositsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_IndemnificationAssetsMember" name="IndemnificationAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_LoansToPhysiciansPartnersMember" name="LoansToPhysiciansPartnersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_MarketableSecuritiesMember" name="MarketableSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_MedicalClaimsAndRelatedPayablesMember" name="MedicalClaimsAndRelatedPayablesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_MedicalServicesExpense1Member" name="MedicalServicesExpense1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_MedicalServicesRevenue1Member" name="MedicalServicesRevenue1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_MedicalServicesRevenueMember" name="MedicalServicesRevenueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_OfficersAndDirectorsMember" name="OfficersAndDirectorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_OneMonthLIBORateMember" name="OneMonthLIBORateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_OptionsVestingMember" name="OptionsVestingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_OtherMedicalExpenses1Member" name="OtherMedicalExpenses1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_OtherMember" name="OtherMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_OtherOperatingRevenue1Member" name="OtherOperatingRevenue1Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_OtherOperatingRevenueMember" name="OtherOperatingRevenueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_PartnerPhysicianGroupEquityAgreementsMember" name="PartnerPhysicianGroupEquityAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_PayorAMember" name="PayorAMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_PayorBMember" name="PayorBMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_PayorCMember" name="PayorCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_PayorDMember" name="PayorDMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_PayorEMember" name="PayorEMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_PayorsMember" name="PayorsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_PriorCreditFacilityAndUnsecuredDebtMember" name="PriorCreditFacilityAndUnsecuredDebtMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_RightOfUseAssetsMember" name="RightOfUseAssetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_SecuredRevolvingFacilityMember" name="SecuredRevolvingFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_SecuredTermLoanAndRevolvingFacilityMember" name="SecuredTermLoanAndRevolvingFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_SecuredTermLoanFacilityMember" name="SecuredTermLoanFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_SouthernCaliforniaOperationsMember" name="SouthernCaliforniaOperationsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_StockOptionsServiceOnlyConditionMember" name="StockOptionsServiceOnlyConditionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_TwoThousandAndTwentyOneOmnibusEquityIncentivePlanMember" name="TwoThousandAndTwentyOneOmnibusEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_TwoThousandAndTwentyOneSecuredRevolvingFacilityMember" name="TwoThousandAndTwentyOneSecuredRevolvingFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_TwoThousandAndTwentyOneSecuredTermLoanAndRevolvingFacilityMember" name="TwoThousandAndTwentyOneSecuredTermLoanAndRevolvingFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_TwoThousandAndTwentyOneSecuredTermLoanFacilityMember" name="TwoThousandAndTwentyOneSecuredTermLoanFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_MedicalServicesRevenuePolicyTextBlock" name="MedicalServicesRevenuePolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="agl_CommitmentsAndContingenciesTable" name="CommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_DescriptionOfBusinessTable" name="DescriptionOfBusinessTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_OtherAssetsTable" name="OtherAssetsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_OtherLiabilitiesTable" name="OtherLiabilitiesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="agl_ConcentrationPolicyTextBlock" name="ConcentrationPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>

↑Top
Filing Submission 0000950170-22-021905   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., May 5, 4:29:59.1pm ET